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A B S T R A C T
Objective: To investigate frequency and practise of termination of pregnancy for early-onset
hypertensive disorders where the fetus is considered to be non-viable.
Study design: Retrospective cohort study in all Dutch tertiary perinatal care centres (n = 10), between
January 2000 and January 2014. All women who underwent termination of pregnancy, without fetal
surveillance or intention to intervene for fetal reasons, for early-onset hypertensive disorders in
pregnancy, were analyzed. Women eligible for this study were identiﬁed in the local delivery databases.
Medical records were used to collect relevant data.
Results: Between January 2000 and January 2014, 2,456,584 women delivered in The Netherlands, of
which 238,448 (9.7%) in a tertiary care centre. A total of 161 pregnancy terminations (11–12 per year) for
severe early-onset preeclampsia were identiﬁed, including 6 women with a twin pregnancy. Mean
gestational age at termination was 172 days (GA 244/7)  9.4 days. In 70% of cases termination was
performed at or shortly after 24 weeks’ gestation. 74.5% of women developed HELLP syndrome (n = 96),
eclampsia (n = 10) or needed admission to an ICU (n = 14). Birth weight was below 500 g in 64% of cases. In
69% of the cases the estimated fetal weight was within a 10% margin of the actual birth weight.
Conclusion: Termination of pregnancy for early-onset hypertensive disorders without intervention for
fetal indication occurs approximately 12 times per year in The Netherlands. More data are needed to
investigate contemporary best practice regarding termination of pregnancy for early-onset hypertensive
indications at the limits of fetal viability. Considering the frequency of maternal complications,
termination of pregnancy and not expectant management should be considered for all women
presenting with severe early onset hypertensive disorders at the limits of fetal viability.
 2016 The Author(s). Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-
NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).* Corresponding author at: Maasstad Ziekenhuis Rotterdam, Department of
Obstetrics and Gynecology, Maasstadweg 21, 3079 DZ Rotterdam, The Netherlands.
E-mail address: eerdenl@maasstadziekenhuis.nl (L. Van Eerden).
http://dx.doi.org/10.1016/j.ejogrb.2016.08.009
0301-2115/ 2016 The Author(s). Published by Elsevier Ireland Ltd. This is an open acce
nc-nd/4.0/).Introduction
The incidence of severe early onset preeclampsia (PE) is
increasing worldwide [1]. Preeclampsia is annually accountable
for approximately 60,000 maternal deaths worldwide. Cerebralss article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
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account for at least 75% of these [2]. In situations where maternal
health is severely compromised and where prognosis for intact
fetal survival is virtually non-existent due to early gestational age
complicated by severe growth restriction, termination of pregnan-
cy may be considered [3–5,10]. In an authoritative review, Sibai
et al. describe a maternal complication rate of 57%, and an overall
fetal mortality rate of 83% when early-onset preeclampsia is
managed expectantly. The authors therefore state that in case of
severe preeclampsia before 24 weeks, termination of pregnancy
should be seriously considered in order to prevent severe maternal
morbidity or mortality [5].
The overall frequency and indications for termination of
pregnancy for maternal indications were recently described by
our group [6]. In the current manuscript we analyzed in more
detail the group of women who presented with early-onset
hypertensive disorders.
Aim of this study is to gain insight in Dutch practice patterns of
all cases of termination of pregnancy for early-onset hypertensive
disorders in pregnancies were the fetus is considered non-viable
over the last 15 years. Secondarily, we aimed to investigate the
accuracy of fetal weight estimation on which fetal prognosis was
based.
Methods
We performed a Dutch nationwide retrospective audit of all
cases of termination of pregnancy for early-onset hypertensive
disorders in pregnancies considered non-viable between January
2000 and January 2014. All womenwho underwent termination of
pregnancy because of severe maternal hypertensive disorders
between 22 and 276/7 [2_TD$DIFF] weeks of pregnancy in tertiary care centres
were included. In all cases the fetus was considered to be non-
viable, either because of the gestational age and/or because of
severe growth restriction. According to Dutch guidelines, valid
during the study period, a fetus at a gestational age of less than
24 weeks was considered non-viable [7]. Exclusion criteria were
termination of pregnancy for other maternal indications, fetal
congenital anomalies or intra-uterine fetal demise. Termination of
pregnancy was deﬁned as termination of a vital pregnancy and
intention of primary non-intervention for fetal indications. All
pregnancies were terminated using prostaglandins (i.e. intrave-
nous sulprostone or misoprostol).
Recruitment was limited to the tertiary care centres (n = 10),
because according to current practice and the Dutch Society of
Obstetrics and Gynaecology guideline on hypertensive disorders in
pregnancy, women who develop preeclampsia prior to 32 weeks’
gestation should be referred to and treated in a tertiary care centre.
These centres are equipped with a maternal obstetric high care
unit as well as a Neonatal Intensive Care Unit (NICU) [8,9]. Cases
were identiﬁed through a search in the local delivery databases. To
control for potential underreporting, we cross-checked the
prevalence data with the Netherlands perinatal registry (PRN-
registry) [10]. Relevant demographic and clinical data were
extracted from the medical records and transferred to a
standardized data collection form. Demographic data included
maternal age at termination, parity, and medical and obstetric
history. Clinical data included information about the index
pregnancy and delivery including gestational age at admission,
gestational age at delivery, birth weight and gender. Furthermore,
speciﬁc data used for clinical decision making were recorded;
gestational age, the last estimated fetal weight (EFW) prior to
termination and suspected growth restriction (EFW < 10th per-
centile).
Deﬁnitions of preeclampsia and HELLP syndrome were derived
from the guidelines of the International Society for the Study ofHypertension in Pregnancy (ISSHP) [11] and the NICE guideline
Hypertension in Pregnancy [12]. Severe preeclampsia is deﬁned as
hypertension (diastolic blood pressure 110 mmHg or systolic
blood pressure 160 mmHg on two occasions) in combination
with proteinuria (deﬁned as a protein/creatinine ratio of 30 mg/
mmol in a random sample or a urine protein excretion of 300 mg
per 24 h) and one or more of the following; oliguria, cerebral or
visual disturbances, pulmonary oedema, epigastric or upper-
quadrant pain, impaired liver function, thrombocytopenia or fetal
growth restriction, after 20 weeks of pregnancy. Severe maternal
morbidity was deﬁned as HELLP syndrome haemolysis (elevated
lactate dehydrogenase (LDH) levels 600 U/L), elevated liver
enzymes by levels of aspartate transaminase (ASAT) 70 U/L or
alanine transferase (ALAT) 70 U/L and low platelets <100,000/
mm), eclampsia or admission to an ICU.
Statistical analysis was performed using SPSS 20.0 (SPSS Inc.,
Chicago, IL, USA). Continuous variables were expressed as means
with standard deviations (SD). We compared estimated fetal
weight by ultrasound and actual birthweight. Differences between
the groups were tested with a parametric (unpaired t-test) test as
appropriate. P value less than 0.05 was considered to indicate
statistical signiﬁcance.
An acknowledged ethical advisory board approved the study
(VUmc # 29-2010/200).
Results
Between January 2000 and January 2014, 2,456,584 women
delivered in The Netherlands, of which 238,448 (9.7%) in a tertiary
care centre. Pregnancy was terminated for early-onset preeclamp-
sia in 161 women (6.5 per 100.000). Among these, 6 women had a
twin pregnancy. A cross-check with the Netherlands Perinatal
Registry demonstrated that 100% of the cases were identiﬁed [9].
Maternal characteristics and outcome are shown in Table 1. The
mean maternal age was 31 years and 116/161 were nulliparous
(72%). The medical history was unremarkable in 82/161 women
(51%).
The mean gestational age at admission was 164 days (233/7
weeks)  9.3 days and at termination this was 172 days (244/7
weeks)  9.4 days. Ninety-two women (57%) were admitted at a
gestational age of less than 24 weeks. In 23/92 women (25%),
induction of labour was commenced immediately after initial
stabilization. In the remaining 69/92 women (75%) pregnancy
management was initially expectant. The mean interval between
admission and start of termination was 9.3 days  5.4 days.
In 113/161 women (70%) termination was started at or beyond
24 weeks (mean GA 252/7  9.4 days). In these cases a multidisci-
plinary team, consisting of at least obstetricians, neonatologists,
discussed the case and examined alternative options before providing
a recommendation to the parents. The main reason to terminate a
pregnancy after 24 weeks’ gestation was rapid maternal deteriora-
tion, such as the development of progressive HELLP syndrome,
eclampsia or refractory hypertension.
No maternal deaths were recorded. One patient with a uterine
scar from a previous caesarean section underwent an emergency
caesarean section after administration of prostaglandins because
of uterine rupture and hypovolemic shock.
Table 2 shows the neonatal characteristics. Data of 167
neonates are available, originating from 155 singleton and 6 twin
pregnancies. The mean birth weight for the entire cohort was
460 g  103 g. Birth weight was below 500 g in 62% of cases. In 145
neonates estimated fetal weight based on antenatal ultrasound
parameters was recorded. The interval betweenmeasurement of EFW
and day of birth was 5.4 days  2.1 days. In 69% of the cases the EFW
was within a 10% margin of the actual birth weight. In 25 cases (22%)
Table 1
Maternal characteristics and outcome. Continuous data are presented as means
(SD) or N (%).
Mean (SD) or
N (%)
Age (y) 30.6 (5.2) N=161
Parity
Nulliparous (no pregnancies>GA 16 weeks) 116 (72)
1 fetal loss <16 weeks 21 (18)
2 or more fetal losses <16 weeks 8 (6.9)
Multiparous 45 (28)
Total number of previous pregnancies 100
Live offspring 57 (57)
Previous perinatal death 15 (15)
Previous termination for maternal indication 2
Fetal loss <16 weeks 15 (33)
Previous PE or HELLP 14 (31)
Previous preterm delivery 13 (62)
Previous term delivery 24 (53)
Medical historya
No preexisting disease 82 (51)
Nulliparous 61
Multiparous 21
Chronic hypertension 33 (21)
Nulliparous 23
Multiparous 10
Thrombophiliab 10 (6.2)
Nulliparous 5
Multiparous 5
Kidney disease 5 (3.1)
Nulliparous 3
Multiparous 2
Otherc 16 (10)
Nulliparous 11
Multiparous 5
Gestational age at onset of termination (weeks) 244/7(220/7–276/7)
9.4 days
22–236/7 weeks 48 (30)
24–256/7 weeks 84 (52)
260/7 weeks 29 (18)
Maternal outcome
Maternal death –
HELLP syndrome 95 (59)
Eclampsia 10 (6.2)
Admission to ICUd 14 (8.4)
a Several women had more than one relevant condition in their history.
b Thrombophilia: antiphospholipid syndrome, protein S deﬁciency, Factor V
Leiden mutation.
c Other: SLE, diabetes mellitus, Crohn’s disease, haemoglobinopathy, malignan-
cy.
d Admission to ICU includes women with pulmonary oedema, refractory
hypertension, eclampsia, heart failure and hypovolemic shock.
Table 2
Neonatal outcome.
Neonatal outcome Mean N=167
n (%)
Sex 167
Male 60 (36)
Female 99 (59)
Unknown 8 (4.9)
Perinatal mortality 166 (99.6)
Birth weight (g) 460103g
>10th percentile 36 (23)
<10th percentile 125 (78)
<5th percentile 106 (66)
Unknown 6 (3.5)
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EFW was more than 10% overestimated.
In the 113 pregnancies that were terminated at or beyond
24 weeks, the mean EFW was 495 g  113 g, while the mean actual
birth weight was 508 g  117 g (mean difference between EFW and
birth weight: 13.3 g; 95%CI:24.30 to2.30; p = 0.018). Fig. 1 shows
the EFW and birth weight per neonate.
Table 3 shows the estimated fetal weight prior to decision of
termination and actual birth weight per gestational week. At a
gestational age of 236/7 the estimated fetal weight or Doppler
proﬁle of the umbilical artery did not play an important role in the
decision to perform termination of pregnancy. The decision to
refrain from fetal monitoring and interventions for fetal indication
was guided by poor fetal prognosis, based on: gestational age, EFW
(51% <500 g), suspected growth restriction (73% EFW < 10th
percentile) and lack of growth between 2 assessments.
The perinatal mortality was 99.6%. One baby girl was born alive
and admitted to the NICU. After 4 years of follow up she has a
normal development. The pregnancy was terminated for severeHELLP syndrome using intravenous sulprostone at a GA of 255/7
weeks. Ultrasound prior to termination showed growth restriction
and oligohydramnios and an EFW of 550 g. The birth weight was
600 g (16th percentile).
The number of terminations per centre per 10,000 deliveries
varied from 2.1 per 10,000 deliveries in one centre to 17.2 per
10,000 deliveries in another centre.
Comment
Main ﬁndings
Between 2000 and 2014, 161women underwent termination of
pregnancy for early-onset hypertensive disorders when the fetus
was considered non-viable (6.5/100,000). The main reason to
terminate was rapid maternal deterioration (progressive HELLP
syndrome, eclampsia or refractory hypertension). In 75% manage-
ment was initially expectant. 75% of women developed HELLP
syndrome, eclampsia or needed admission to an ICU. In the
majority of women (70%) termination was performed at or beyond
24 weeks. For the decision to refrain from fetal monitoring and
active neonatal support the following parameters were taken into
consideration: gestational age, estimated fetal weight, growth
restriction, and lack of interval growth. In 31% of the cases EFWwas
more than 10% underestimated or overestimated compared to the
actual birth weight. All terminations were performed medically.
Strengths and weaknesses
This study describes a large nationwide cohort, considering the
rareness of the condition. These data ﬁll a knowledge gap
concerning the frequency of termination of pregnancy for
hypertensive disorders and concerning factors contributing to
the decision to do so. Furthermore, detailed medical history and
outcome information is available since data was gathered from the
medical records. During the study period national guidelines for
management of pre-eclampsia remained unchanged [8,9].
The most important limitation is that this is a retrospective
study. We did however put a major effort to ensure completeness
of cases.
Interpretation
Gestational age and fetal growth
In this cohort, 57% of women were admitted prior to a
gestational age of 24 weeks’. Despite international literature and
guidelines, stating that such women should be counselled towards
termination, 75% of these pregnancies were initially managed
expectantly and prolonged with 9.3 days on average. Expectant
management resulted in signiﬁcant maternal deterioration such
that termination was considered inevitable.
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0
100
200
300
400
500
600
700
800
900
0 20 40 60 80 100 120
Fig. 1. Estimated fetal weight and actual birth weight per case.
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between 240/7 and 326/7 weeks’ gestation, obstetric management
will depend on prospects for intact survival of the infant [3–5]. This
study presents a cohort that progressed beyond 24 weeks where
disease severity and non-viable prognosis for the fetus led to the
difﬁcult decision to terminate the pregnancy precluding infant
survival. In these cases prolongation of pregnancy with a risk of
severe maternal complications but also a potential increase in
number of surviving infants was weighed against termination of
pregnancy with probable reduction of maternal complications but
increased perinatal mortality. This decision was made after
interdisciplinary consultation and parent counselling. Studies onTable 3
Estimated fetal weight (EFW) and actual birth weight, according to gestational age
in weeks.
Gestational age
at termination
Neonates
(N)
Prenatal EFW
N (%)
Birth weight N (%)
220–226 22 <500g: 20 (100)
500g: –
Unknown: 2
<500g: 21 (100)
500g: 0
Unknown: 1
230–236 28 <500g: 19 (90)
500g: 2 (10)
Unknown: 7
<500g: 24 (100)
500g: 0
Unknown: 4
240–246 43 <500g: 29 (71)
500g: 12 (29)
Unknown: 2
<500g: 27 (64)
500g: 15 (36)a
Unknown: 1
250–256 45 <500g: 21 (51)
500g: 20 (49)
Unknown: 4
<500g: 23 (51)
500g: 22 (49)b
260–266 23 <500g: 5 (26)
500g: 14 (74)
Unknown: 4
<500g: 7 (30)
500g: 16 (70)c
270–276 6 <500g: 2 (33)
500g: 4 (66)
Unknown: –
<500g: 1 (17)
500g: 5 (83)d
Percentages are shown according to the number of available records.
a Mean 560g117 g.
b Mean 593g117 g.
c Mean 612g122 g.
d Mean 578g121 g.perinatal mortality and morbidity in these severely growth
restricted premature infants do not support active neonatal
management [13–16].
The accuracy of fetal weight estimation by ultrasound has been
debated [17]. A recent study shows that determining the EFW in
extreme preterm and SGA fetuses is less accurate than for AGA
fetuses and that EFW is more likely to be overestimated [17]. Our
study shows that in 22% of neonates theweight wasmore than 10%
higher than estimated before birth. We recommend to take this
inaccuracy into account when counselling parents with growth
restricted fetuses at the limits of fetal viability.
Conclusion
Termination of pregnancy for early-onset hypertensive dis-
orders in fetuses considered non-viable, is extremely rare in The
Netherlands. We identiﬁed on average 1–2 cases per year per
tertiary obstetric care centre. To reach the decision to terminate
such pregnancies at the limits of fetal viability is very difﬁcult for
parents as well as health care providers. This is reﬂected in an
average interval between admission and intervention of 9.3 days.
However, considering the frequency of maternal complications
termination of pregnancy and not expectant management should
be considered for all women presenting with severe early onset
hypertensive disorders at the limits of fetal viability. As neonatal
intensive care continues to improve and enables survival at earlier
gestational ages and lower birth weights it is prudent to
continuously monitor the practice and outcomes to be able to
deﬁne best-practices in the care of these complicated pregnancies.
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